Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista de Economía Institucional
versión impresa ISSN 0124-5996
Resumen
KAILA, Ilari y MAKINEN, Joona-Hermanni. Finland Had a Patent-Free COVID-19 Vaccine Nine Months Ago - But Still Went With Big Pharma. Rev.econ.inst. [online]. 2021, vol.23, n.45, pp.257-264. Epub 01-Sep-2022. ISSN 0124-5996. https://doi.org/10.18601/01245996.v23n45.12.
Moderna received 2.5 billion in public support in the United States. Researchers at the University of Helsinki needed 50 million for phase III of their patent-free vaccine. But they did not get any help from the state, despite the fact that a social democratic party is in power.
Palabras clave : Covid-19, vaccines, patents, big pharma, public funding, private profit; JEL: I13, I28, I39.